Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Personalis Inc (PSNL)

Personalis Inc (PSNL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 303,196
  • Shares Outstanding, K 31,129
  • Annual Sales, $ 37,774 K
  • Annual Income, $ -19,886 K
  • 60-Month Beta N/A
  • Price/Sales 5.04
  • Price/Cash Flow N/A
  • Price/Book 2.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.89
  • Most Recent Earnings -0.22 on 11/13/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.26
  • Number of Estimates 3
  • High Estimate -0.20
  • Low Estimate -0.31
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.70 +2.18%
on 11/18/19
12.43 -28.47%
on 10/22/19
-3.01 (-25.29%)
since 10/18/19
3-Month
8.70 +2.18%
on 11/18/19
20.74 -57.14%
on 08/20/19
-9.16 (-50.75%)
since 08/16/19

Most Recent Stories

More News
Personalis: 3Q Earnings Snapshot

MENLO PARK, Calif. (AP) _ Personalis Inc. (PSNL) on Wednesday reported a loss of $6.9 million in its third quarter.

PSNL : 8.89 (-8.73%)
Personalis, Inc. to Present at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2019

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will participate in the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer...

PSNL : 8.89 (-8.73%)
Personalis Appoints Karin Eastham to Its Board of Directors

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that it has appointed Karin Eastham as an independent director to its Board of Directors. Ms. Eastham brings more...

ILMN : 306.67 (+0.22%)
MOR : 28.20 (+8.00%)
VCYT : 25.44 (+0.79%)
PSNL : 8.89 (-8.73%)
Personalis to Participate in the 17th Annual Morgan Stanley Global Healthcare Conference

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the company will participate at the upcoming 17th Annual Morgan Stanley Global Healthcare Conference being held...

MS : 49.03 (+0.08%)
PSNL : 8.89 (-8.73%)
Personalis: 2Q Earnings Snapshot

MENLO PARK, Calif. (AP) _ Personalis Inc. (PSNL) on Tuesday reported a loss of $5.9 million in its second quarter.

PSNL : 8.89 (-8.73%)
Personalis Announces Closing of Initial Public Offering and Exercise in Full of Over Allotment Option

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the closing of its initial public offering of 9,109,725 shares of common stock at a public offering price of $17.00...

MS : 49.03 (+0.08%)
PSNL : 8.89 (-8.73%)
Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman

Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it has appointed Patrick J. Balthrop, Sr. as Chairman of its board of directors....

OXFD : 16.73 (+0.72%)
PSNL : 8.89 (-8.73%)
Trade PSNL with:

Business Summary

Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.

See More

Key Turning Points

2nd Resistance Point 10.16
1st Resistance Point 9.53
Last Price 8.89
1st Support Level 8.48
2nd Support Level 8.06

See More

52-Week High 31.88
Fibonacci 61.8% 23.03
Fibonacci 50% 20.29
Fibonacci 38.2% 17.55
Last Price 8.89
52-Week Low 8.70

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar